Kalisvar Marimuthu
Overview
Explore the profile of Kalisvar Marimuthu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
84
Citations
4356
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Reyes J, Komarow L, Chen L, Ge L, Hanson B, Cober E, et al.
Lancet Microbe
. 2023 Feb;
4(3):e159-e170.
PMID: 36774938
Background: Carbapenem-resistant Pseudomonas aeruginosa (CRPA) is a global threat, but the distribution and clinical significance of carbapenemases are unclear. The aim of this study was to define characteristics and outcomes...
12.
Chan C, Wong S, Yazid N, Ng O, Marimuthu K, Chan M, et al.
J Infect Dis
. 2022 Oct;
227(8):1002-1006.
PMID: 36200239
Serological testing of Singaporeans who received childhood smallpox vaccination found anti-vaccinia IgG binding and neutralizing activity indicating long-term humoral immunity. There was correlation between IgG and neutralizing titers indicating IgG...
13.
Kang J, Teo J, Bertrand D, Ng A, Ravikrishnan A, Yong M, et al.
Nat Microbiol
. 2022 Sep;
7(10):1516-1524.
PMID: 36109646
Long-term colonization of the gut microbiome by carbapenemase-producing Enterobacteriaceae (CPE) is a growing area of public health concern as it can lead to community transmission and rapid increase in cases...
14.
Teo J, Octavia S, Prakki S, Venkatachalam I, Marimuthu K, Ng O
Antimicrob Agents Chemother
. 2022 Aug;
66(9):e0101922.
PMID: 36036602
No abstract available.
15.
Ng O, Marimuthu K, Lim N, Lim Z, Thevasagayam N, Koh V, et al.
JAMA Netw Open
. 2022 Aug;
5(8):e2228900.
PMID: 36018588
Importance: Assessing booster effectiveness of COVID-19 mRNA vaccine and inactivated SARS-CoV-2 vaccine over longer time intervals and in response to any further SARS-CoV-2 variants is crucial in determining optimal COVID-19...
16.
Chakraborty N, Jha D, Roy I, Kumar P, Singh Gaurav S, Marimuthu K, et al.
J Nanobiotechnology
. 2022 Aug;
20(1):375.
PMID: 35953826
Given the spasmodic increment in antimicrobial resistance (AMR), world is on the verge of "post-antibiotic era". It is anticipated that current SARS-CoV2 pandemic would worsen the situation in future, mainly...
17.
Marimuthu K, Venkatachalam I, Koh V, Harbarth S, Perencevich E, Cherng B, et al.
Nat Commun
. 2022 Jun;
13(1):3052.
PMID: 35650193
Carbapenemase-producing Enterobacterales (CPE) infection control practices are based on the paradigm that detected carriers in the hospital transmit to other patients who stay in the same ward. The role of...
18.
Ong S, Rao P, Khong W, Ong V, Sai Rama Sridatta P, Thevasagayam N, et al.
Infect Control Hosp Epidemiol
. 2022 May;
44(3):460-466.
PMID: 35603837
Objective: In our center, previous infection prevention and control (IPC) resources were concentrated on multidrug-resistant organisms other than CRAB because the rate of CRAB was stable with no evidence of...
19.
Ng O, Koh V, Chiew C, Marimuthu K, Thevasagayam N, Mak T, et al.
Clin Infect Dis
. 2022 Mar;
75(1):e35-e43.
PMID: 35323887
Background: In Singapore, quarantine of all close contacts with entry and exit polymerase chain reaction testing enabled evaluation of the impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination...
20.
Li W, Mao F, Ng C, Jong M, Goh S, Charles F, et al.
Environ Int
. 2022 Mar;
163:107185.
PMID: 35306253
Sewage-based surveillance is widely employed to understand the occurrence and distribution of antimicrobial resistance (AMR) in urban community. However, there are limited studies which investigated the sewage of different sources...